![Joseph Lobacki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Lobacki
Direktor/Vorstandsmitglied bei
SUTRO BIOPHARMA, INC.
Vermögen: - $ am 31.05.2026
Profil
Joseph M.
Lobacki is currently an Independent Director at Sutro Biopharma, Inc. since 2017.
Formerly, Mr. Lobacki was President, Chief Executive Officer & Director at Artax Biopharma, Inc. from 2020 to 2024; Chief Commercial Officer & Executive Vice President at Verastem, Inc. from 2018 to 2019; Chief Operating Officer at Finch Research & Development LLC from 2016 to 2017; Chief Operating Officer at Finch Therapeutics Group, Inc. from 2013 to 2017; Chief Commercial Officer & Council Member at Medivation LLC (California) from 2014 to 2016; Independent Director at Jazz Pharmaceuticals Therapeutics, Inc. from 2013 to 2016; Chief Commercial Officer & Senior Vice President at Amgen Rockville, Inc. from 2011 to 2014; General Manager-Oncology Business at Idera Pharmaceuticals, Inc. from 2012 to 2014; Senior Vice President, General Manager-Transplant & Oncology at Genzyme Corp.
from 2003 to 2011.
Other former roles include Vice President-North American Marketing at SangStat Medical Corp., Vice President-Operations at Cell Pathways, Inc., and Chief Commercial Officer & Senior Vice President at Micromet, Inc. Education includes undergraduate degrees from Boston College in 1980 and Massachusetts College of Pharmacy & Health Science in 1983.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Joseph Lobacki
| Unternehmen | Position | Beginn |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.02.2017 |
Ehemalige bekannte Positionen von Joseph Lobacki
| Unternehmen | Position | Ende |
|---|---|---|
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Vorstandsvorsitzender | 04.01.2024 |
| VERASTEM, INC. | Corporate Officer/Principal | 01.01.2019 |
Finch Research & Development LLC
 Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Geschäftsführer | 01.12.2017 |
| FINCH THERAPEUTICS GROUP, INC. | Geschäftsführer | 01.12.2017 |
| MEDIVATION INC | Corporate Officer/Principal | 01.10.2016 |
Ausbildung von Joseph Lobacki
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
SangStat Medical Corp.
 SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation | Health Technology |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Finch Research & Development LLC
Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Micromet Inc.
 Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
